Gene News and Research

Latest Gene News and Research

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.

25 Sep 2018

Your Vision Matters: How to Protect Your Eyesight

Dr. Neil Ebenezer from the charity Fight for Sight discusses the steps you can take to protect your eyesight into old age, and why research into ophthalmic diseases is desperately needed.

24 Sep 2018

Gene therapy approach could help treat mitochondrial diseases

Researchers have developed a genome-editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people.

24 Sep 2018

Ecstasy drug makes octopuses more social

When people take MDMA, the drug popularly known as ecstasy, a rush of serotonin, dopamine, and oxytocin produces feelings of emotional closeness and euphoria, making people more interested than they would normally be in connecting and sharing with other people.

24 Sep 2018

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

Harnessing the immune system to treat cancer shows great promise in some patients, but for many, the response does not last long-term.

24 Sep 2018

National Eye Health Week 2018: Paralympic medalists support Fight for Sight’s unique virtual event

Paralympic medallists are supporting Fight for Sight’s massive adventure on a small scale, with the launch of a unique virtual event today for National Eye Health Week 2018.

24 Sep 2018

SNMMI announces recipients of 2018-2020 Wagner-Torizuka Fellowship

The Society of Nuclear Medicine and Molecular Imaging is pleased to announce the recipients of the 2018-2020 SNMMI Wagner-Torizuka Fellowship.

24 Sep 2018

Columbia University announces winners of 2018 Louisa Gross Horwitz Prize

Columbia University has decided to award the Louisa Gross Horwitz Prize 2018.

24 Sep 2018

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.

24 Sep 2018

Academics receive prestigious awards for achievements in blood pressure research

Two academics from Queen Mary University of London have received prestigious awards from the International Society of Hypertension 2018 in recognition of their achievements in blood pressure research.

24 Sep 2018

New research suggests power of zebrafish as tool for cancer drug discovery

The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes.

24 Sep 2018

Researchers identify new genetic disorder in a human patient

Researchers from Michigan State University College of Human Medicine and physicians from Spectrum Health have identified for the first time in a human patient a genetic disorder only previously described in animal models.

21 Sep 2018

Insulin treatment shows great potential against chronic bowel inflammation

Millions of people take insulin every day to treat their diabetes. But diabetes is not the only disease on which insulin has an effect, it appears.

21 Sep 2018

Study opens new avenues for treatment of Laing distal myopathy

New avenues are now being opened for future treatment of Laing distal myopathy, a rare disorder that causes muscles in the feet, hands and elsewhere to atrophy. In a study published in the journal PNAS, researchers have identified an enzyme with a clear link to how the disease develops.

21 Sep 2018

Gene News and Research

Latest Gene News and Research

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Your Vision Matters: How to Protect Your Eyesight

Gene therapy approach could help treat mitochondrial diseases

Ecstasy drug makes octopuses more social

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

National Eye Health Week 2018: Paralympic medalists support Fight for Sight’s unique virtual event

SNMMI announces recipients of 2018-2020 Wagner-Torizuka Fellowship

Columbia University announces winners of 2018 Louisa Gross Horwitz Prize

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Academics receive prestigious awards for achievements in blood pressure research

New research suggests power of zebrafish as tool for cancer drug discovery

Researchers identify new genetic disorder in a human patient

Insulin treatment shows great potential against chronic bowel inflammation

Study opens new avenues for treatment of Laing distal myopathy

Study shows how the drive to eat overpowers the brain’s signal to stop

Overlooked immune cells could play a key role in cancer immunotherapy, claims new study

Scientists report conserved role for serotonin in mediating social behavior in octopus, humans

New federally-funded research project could lead to treatments that extend human lifespan

Dopamine neurons may involve in conditions ranging from Parkinson's disease to schizophrenia

Study: Neural signal that urges to eat overpowers the one that says to stop

Genomics - Industry Focus eBook (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research